Results · Apr-Jun 2026 · filed 7 Aug 2026
Poly Medicure Q1 FY27 results
Sales grew 30% to ₹525 crore from ₹403 crore in Apr-Jun 2025.
Operating profit grew 18% to ₹125 crore, an operating margin of 23.8% (down 2.5 points from a year ago).
Net profit fell 8% to ₹85.3 crore from ₹93.1 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −2%, net profit +31%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 525.4 | 403.2 | +30% |
| Operating profit (EBITDA) | 125.1 | 106.1 | +18% |
| Operating margin | 23.8% | 26.3% | −2.5 pts |
| Net profit | 85.3 | 93.1 | −8% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 10 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 10 Aug 2026Statement Of Deviation & Variation For The Quarter Ended 30Th June, 2026
- 10 Aug 2026Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- 10 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Change in Management
- 7 Aug 2026The Company Granted The 1476 ESOP Options To The Employees Under The ESOP Scheme, 2020.
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.